🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨Extendimos el deadline para recibir resúmenes de trainees!! No te pierdas esta oportunidad!!! 🗓️Día de exposición: 30 de Octubre 📑Abstract: 300 palabras máx ⌛️Tiempo: 15 min de exposición + 5 min de preguntas 🔚Deadline: 15 de Agosto 📩Enviar a: [email protected]

🎉🌟Yesterday, our team members had an amazing off-site meeting! 🤝💡 It was a great opportunity to brainstorm and exchange new ideas. 🚀🌈 #Teamwork #Innovation #Success #wearefecundis

🚀 Thrilled to be part of the CRAASH 2023 program with the incredible Fecundis team! Ready to dive in, learn, and connect with motivated entrepreneurs. Big thanks to Biocat and @CIMIT for this invaluable opportunity! #startuplife #challenge #motivation #CRAASH2023

Happy to share our new paper. Reorganization of the Flagellum Scaffolding Induces a Sperm Standstill During Fertilization | bioRxiv biorxiv.org/content/10.110…

Gestionar talento es conocer las capacidades y atributos de cada uno, acompañar en el proceso de desarrollo y crecimiento, fomentando la superación y motivación, y buscando que el camino sea de disfrute y no una tortura Andrés Hatum #MBAVB22UTDT

🛑Do you work in ART? This message is for you!🛑 Fecundis is developing a technology to improve patient outcomes and clinical operations. We want to adapt to your clinic needs; take this anonymous 2 minutes survey and let your voice be heard! docs.google.com/forms/d/e/1FAI…

📢 Do you want to join us? We are looking for a passionate researcher to be part of our R&D team! 🔬 Check out the description and apply by December 15th.⭐️ #science #reproduction #ivf #sperm #embryo #team #wearefecundis

📢 JOB OPENING! 🧑‍🔬Buscamos un perfil investigador para nuestra unidad de I+D en Buenos Aires 🇦🇷. ¿Tenés experiencia en #reproducción y querés ser parte de un equipo de excelencia científica que cree valor para pacientes y clínicas? Te estamos buscando! #investigación #jobalert

The Fecundis Lab team wishes you a happy, peaceful and restful holiday season! 🎄 We are taking a few days off to recharge and relax with family and friends, but do not worry, we’ll be back soon!! 💥 #holidayseason #christmas2023 #feliznavidad

📢 Big news! Our doors are open to investments! 🚀We are off to a great start of our Capital Cell  campaign! This #crowdfunding is your chance to own part of Fecundis as we move to shape the future of #fertility treatments. ⭐️Secure your investment: capitalcell.es/campaign/fecun…

📢 WE ARE HIRING! 📢 We are looking for a Regulatory and Quality Specialist to join our team in Barcelona! 🇪🇸🏖 Passionate about quality systems for cutting-edge medical device development? Want to impact millions of lives and work with flexibility? We want to talk to you!😉

Excited with our new acquisition! 🤓🤩

#RESI2024 is underway in Barcelona! Thrilled to see Fecundis participating in the Innovator’s Pitch Challenge, connecting with top investors and industry experts in the biotech sector. Exciting times for early-stage life science innovations! #biotech #startup #investment 🚀

.Parc Científic de Barcelona : Fecundis levanta 2,4 millones de euros en una ronda de financiación semilla biotech-spain.com/es/articles/fe…

#PCBCommunity | Fecundis, a clinical-stage company focused on developing disruptive technology in #fertility. secures $2.4 million in a seed funding round 👉bit.ly/3NgQUNn Congrats Dario Krapf Mariano G Buffone Rita Vassena & team! 💪🤗 DuneGlass Capital GRIDX

Fecundis is developing faster, cheaper & more successful #fertilitytreatments, by innovative sperm focused technologies, that mitigate the economic & psychological impact of the #assistedhumanreproduction procedures. Dario Krapf Mariano G Buffone Rita Vassena #HyperSperm

Fecundis capta 2,4 millones de euros para su tratamiento pionero de la #infertilidad por actuar sobre el espermatozoide 📰 El Periódico ✍️ Informa Paula Clemente Rita Vassena Dario Krapf Mariano G Buffone DuneGlass Capital GRIDX elperiodico.com/es/economia/20…

Happy to share our latest results in eLife - the journal on our discoveries regarding the fertilization process in mammals. Congratulations to the team! Adan Oswaldo Guerrero Cardenas Martina Jabloñski Guillermina Luque Matías Gómez Elías Dario Krapf Fundación IBYME Chan Zuckerberg Initiative elifesciences.org/articles/93792

🚀 Check out our latest study in eLife - the journal exploring changes in sperm flagellum structure during #fertilization 🔬. Huge congratulations to our incredible team for this achievement! 👏 Mariano G Buffone Dario Krapf Guillermina Luque Matías Gómez Elías #research 🔗doi.org/10.7554/eLife.…

Orgulloso de nuestro trabajo en Fecundis! Nuestra tecnología HyperSperm muestra mejor desarrollo embrionario, mayor implantación y un perfil de seguridad excelente. ¡Un gran hito para todo el equipo! 🙌 FBIOyF UNR Facultad Cs Bioquímicas y Farmacéuticas UNR Fecundis IBR conicet.gov.ar/tecnologia-des…